The New Frontiers in Neurodegenerative Diseases Treatment: Liposomal-Based Strategies

Frontiers in Bioengineering and Biotechnology
Mariafrancesca CascioneRosaria Rinaldi

Abstract

In the last decade, the onset of neurodegenerative (ND) diseases is strongly widespread due to the age increase of the world population. Despite the intensive investigations boosted by the scientific community, an efficacious therapy has not been outlined yet. The drugs commonly used are only able to relieve symptom severity; following their oral or intravenous administration routes, their effectiveness is strictly limited due to their low ability to reach the Central Nervous System (CNS) overcoming the Blood Brain Barrier (BBB). Starting from these assumptions, the engineered-nanocarriers, such as lipid-nanocarriers, are suitable agents to enhance the delivery of drugs into the CNS due to their high solubility, bioavailability, and stability. Liposomal delivery systems are considered to be the ideal carriers, not only for conventional drugs but also for neuroprotective small molecules and green-extracted compounds. In the current work, the LP-based drug delivery improvements in in vivo applications against ND disorders were carefully assessed.

References

May 1, 1990·Trends in Neurosciences·W Risau, H Wolburg
Jan 1, 1989·Methods in Enzymology·M C Woodle, D Papahadjopoulos
Mar 1, 1996·Molecular Medicine Today·N J Abbott, I A Romero
Mar 4, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·E TouitouM Eliaz
Feb 23, 2002·Drug Development and Industrial Pharmacy·P R LockmanD D Allen
Oct 26, 2002·Science·Dennis J Selkoe
Oct 31, 2002·Nature Neuroscience·Martin Citron
Nov 5, 2002·Annual Review of Pharmacology and Toxicology·A G de BoerP J Gaillard
Jan 18, 2003·Vascular Pharmacology·J M Scherrmann
Dec 17, 2003·Progress in Drug Research. Fortschritte Der Arzneimittelforschung. Progrès Des Recherches Pharmaceutiques·David J Begley, Milton W Brightman
Mar 24, 2004·Seminars in Cell & Developmental Biology·Michel Goedert
Apr 20, 2004·European Journal of Pharmacology·Bruce S McEwen, Lawrence P Reagan
Jul 24, 2004·Nature Medicine·Christopher A Ross, Michelle A Poirier
Nov 25, 2005·Current Drug Delivery·Y ChenH A E Benson
Feb 17, 2006·Mechanisms of Ageing and Development·Sibani Sarkar, Nirmalendu Das
Mar 15, 2006·Yi chuan xue bao = Acta genetica Sinica·Yan-Hong LiLing Yang
Jul 6, 2006·Trends in Biochemical Sciences·Danny M HattersKarl H Weisgraber
Sep 12, 2006·Annual Review of Pharmacology and Toxicology·A G de Boer, P J Gaillard
Oct 24, 2006·Chemical Society Reviews·Larken E EulissJoseph DeSimone
Jun 16, 2007·Advanced Drug Delivery Reviews·Paolo BlasiCarlo Rossi
Dec 22, 2007·Expert Opinion on Drug Delivery·David B Fenske, Pieter R Cullis
Mar 14, 2008·Toxicologic Pathology·David B FenskePieter R Cullis
Aug 30, 2008·The AAPS Journal·Françoise HervéJean-Michel Scherrmann
Dec 24, 2008·Acta Pharmaceutica : a Quarterly Journal of Croatian Pharmaceutical Society and Slovenian Pharmaceutical Society, Dealing with All Branches of Pharmacy and Allied Sciences·Karthik ArumugamNayanabhirama Udupa
May 19, 2009·Nanomedicine : Nanotechnology, Biology, and Medicine·B MishraSanjay Tiwari
Aug 12, 2009·Neurobiology of Disease·N Joan AbbottDavid J Begley
Oct 31, 2009·Journal of Controlled Release : Official Journal of the Controlled Release Society·Chengjun ChenXing Tang
Jun 16, 2010·Neuron·Ted M DawsonValina L Dawson
Sep 21, 2010·Clinical Interventions in Aging·Werner PoeweFrançois Vingerhoets
Dec 22, 2010·AAPS PharmSciTech·Surajit Das, Anumita Chaudhury
Mar 12, 2011·Expert Opinion on Drug Delivery·Antonio Di StefanoPiera Sozio
Aug 13, 2011·Current Pharmaceutical Design·A L Bartels
Dec 14, 2011·Advanced Drug Delivery Reviews·Yan Chen, Lihong Liu
Jan 4, 2012·Current Pharmaceutical Design·Fei LiJingshan Shi
Jan 11, 2012·Methods in Enzymology·William M Pardridge, Ruben J Boado
Feb 23, 2012·Cold Spring Harbor Perspectives in Medicine·Leonidas Stefanis

❮ Previous
Next ❯

Citations

Sep 22, 2021·Analytical Chemistry·Pauline LefrançoisStéphane Arbault

❮ Previous
Next ❯

Methods Mentioned

BETA
chemical modification
transfection

Related Concepts

Related Feeds

Blood Brain Barrier

The blood brain barrier is a border that separates blood from cerebrospinal fluid. Discover the latest search on this highly selective semipermeable membrane here.

Blood Brain Barrier Chips

The blood brain barrier (BBB) is comprised of endothelial cells that regulate the influx and outflux of plasma concentrations. Lab-on-a-chip devices allow scientists to model diseases and mechanisms such as the passage of therapeutic antibodies across the BBB. Discover the latest research on BBB chips here.

Related Papers

Journal of Controlled Release : Official Journal of the Controlled Release Society
Amna AkhtarMuhammad Yar
Journal of Controlled Release : Official Journal of the Controlled Release Society
Lindsey CrawfordDavid Putnam
© 2021 Meta ULC. All rights reserved